| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.2 | 2e-05 |